{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:27:24Z","timestamp":1775104044732,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ccc.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:24:17Z","timestamp":1622096657000},"page":"563-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cardiovascular Drug Toxicity"],"prefix":"10.1016","volume":"37","author":[{"given":"Maude","family":"St-Onge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ccc.2021.03.006_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","article-title":"2016 Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th annual report","volume":"55","author":"Gummin","year":"2017","journal-title":"Clin Toxicol"},{"issue":"9","key":"10.1016\/j.ccc.2021.03.006_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/15563650.2019.1708376","article-title":"To call or not to call: behavioral determinants influencing the decision of intensivist to consult poison centers for calcium channel blocker poisoning","volume":"58","author":"Brassard","year":"2020","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.ccc.2021.03.006_bib4","first-page":"115","article-title":"Classification of antidysrhythmic drugs","volume":"1","author":"Vaughan Williams","year":"1975","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ccc.2021.03.006_bib5","author":"Srinivasan"},{"key":"10.1016\/j.ccc.2021.03.006_bib6","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","article-title":"Chapter 30: antiarrhythmic drugs","author":"Knollmann","year":"2018"},{"issue":"3","key":"10.1016\/j.ccc.2021.03.006_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ams2.284","article-title":"Efficacy of isoproterenol for treating amlodipine overdose resulting in bradycardia","volume":"4","author":"Ebihara","year":"2017","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.ccc.2021.03.006_bib8","series-title":"Goldfrank\u2019s toxicologic emergencies","first-page":"945","article-title":"Chapter 60: calcium channel blockers","author":"Hang","year":"2019"},{"issue":"9","key":"10.1016\/j.ccc.2021.03.006_bib9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/01.CCM.0000278916.04569.23","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil","volume":"35","author":"Levine","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2021.03.006_bib10","series-title":"Goldfrank\u2019s toxicologic emergencies","first-page":"926","article-title":"Chapter 59: \u03b2-adrenergic antagonists","author":"Brubacher","year":"2019"},{"key":"10.1016\/j.ccc.2021.03.006_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2021.03.006_bib12","series-title":"Goldfrank\u2019s toxicologic emergencies","first-page":"969","article-title":"Chapter 62: Cardioactive steroids","author":"Hack","year":"2019"},{"key":"10.1016\/j.ccc.2021.03.006_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/15563657308990513","article-title":"Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications","volume":"6","author":"Bismuth","year":"1973","journal-title":"Clin Toxicol"},{"issue":"7","key":"10.1016\/j.ccc.2021.03.006_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/15563650.2018.1546010","article-title":"Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATMO-4)","volume":"57","author":"Chan","year":"2019","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ccc.2021.03.006_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157340312801784961","article-title":"Utility of the electrocardiogram in drug overdose and poisoning: theoretical considerations and clinical implications","volume":"8","author":"Yates","year":"2012","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"10.1016\/j.ccc.2021.03.006_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/15563650.2014.965827","article-title":"Treatment for calcium channel blocker poisoning: a systematic review","volume":"52","author":"St-Onge","year":"2014","journal-title":"Clin Toxicol"},{"issue":"7","key":"10.1016\/j.ccc.2021.03.006_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/15563650.2011.593522","article-title":"High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock","volume":"49","author":"Holger","year":"2011","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.ccc.2021.03.006_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1553-2712.2010.00695.x","article-title":"Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model","volume":"17","author":"Holger","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"10","key":"10.1016\/j.ccc.2021.03.006_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/15563650.2016.1214275","article-title":"Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning","volume":"54","author":"Gosselin","year":"2016","journal-title":"Clin Toxicol"},{"issue":"10","key":"10.1016\/j.ccc.2021.03.006_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650.2020.1752918","article-title":"Treatment for beta-blocker poisoning: a systematic review","volume":"58","author":"Rotella","year":"2020","journal-title":"Clin Toxicol"},{"issue":"5","key":"10.1016\/j.ccc.2021.03.006_bib22","first-page":"394","article-title":"Glucagon therapy for beta-blocker overdose","volume":"18","author":"Peterson","year":"1984","journal-title":"Drug Intell Clin Pharm"},{"issue":"7821","key":"10.1016\/j.ccc.2021.03.006_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(73)93111-5","article-title":"Treatment of digoxin intoxication","volume":"2","author":"Hartel","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2021.03.006_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/15563650.2014.943907","article-title":"Digoxin-specific antibody fragment in the treatment of digoxin toxicity","volume":"52","author":"Chan","year":"2014","journal-title":"Clin Toxicol"},{"issue":"7","key":"10.1016\/j.ccc.2021.03.006_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/15563650.2018.1546010","article-title":"Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4)","volume":"57","author":"Chan","year":"2019","journal-title":"Clin Toxicol"},{"issue":"6","key":"10.1016\/j.ccc.2021.03.006_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/15563650.2016.1175620","article-title":"Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)","volume":"54","author":"Chan","year":"2016","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.ccc.2021.03.006_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13181-015-0483-y","article-title":"A\u00a0literature review of the use of sodium bicarbonate for the treatment of QRS widening","volume":"12","author":"Bruccoleri","year":"2016","journal-title":"J\u00a0Med Toxicol"},{"issue":"4","key":"10.1016\/j.ccc.2021.03.006_bib28","first-page":"331","article-title":"Variability of recommendations for serum alkalinization in tricyclic antidepressant overdose: a survey of US Poison Center medical directors","volume":"41","author":"Seger","year":"2003","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.ccc.2021.03.006_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1553-2712.1994.tb02733.x","article-title":"Recovery from severe cyclic antidepressant overdose with hypertonic saline\/dextran in a swine model","volume":"1","author":"McCabe","year":"1994","journal-title":"Acad Emerg Med J"},{"issue":"2","key":"10.1016\/j.ccc.2021.03.006_bib30","first-page":"249","article-title":"Hypertonic NaCl antagonizes cardiac arrhythmia induced by bupivacaine","volume":"22","author":"Scalabrini","year":"1989","journal-title":"Braz Med Biol Res"},{"issue":"4","key":"10.1016\/j.ccc.2021.03.006_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-200104000-00041","article-title":"Successful extracorporeal life support in a case of severe flecainide intoxication","volume":"29","author":"Auzinger","year":"2001","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccc.2021.03.006_bib32","doi-asserted-by":"crossref","first-page":"1542.e1","DOI":"10.1016\/j.ajem.2015.07.054","article-title":"Successful treatment of flecainide-induced cardiac arrest with extracorporeal membrane oxygenation in the ED","volume":"33","author":"Reynolds","year":"2015","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.ccc.2021.03.006_bib33","first-page":"90","article-title":"Flecainide toxicity-treatment with intravenous fat emulsion and extra-corporeal life-support","volume":"15","author":"Sivalingam","year":"2013","journal-title":"Acute Cardiol Care"},{"issue":"3","key":"10.1016\/j.ccc.2021.03.006_bib34","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1097\/CCM.0000000000002087","article-title":"Expert consensus recommendations for the management of calcium channel blocker poisoning in adults","volume":"45","author":"St-Onge","year":"2017","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2021.03.006_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/15563650.2016.1180390","article-title":"A\u00a0systematic analysis of methylene blue for drug-induced shock","volume":"54","author":"Warrick","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ccc.2021.03.006_bib37","doi-asserted-by":"crossref","first-page":"103400","DOI":"10.1016\/j.etap.2020.103400","article-title":"Digoxin: pharmacology and toxicology \u2013 a review","volume":"79","author":"Patocka","year":"2020","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"10.1016\/j.ccc.2021.03.006_bib39","first-page":"261","article-title":"Acute digitalis intoxication \u2013 is pacing still appropriate?","volume":"31","author":"Taboulet","year":"1993","journal-title":"Clin Toxicol"},{"issue":"30","key":"10.1016\/j.ccc.2021.03.006_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000080483","article-title":"Safety of transvenous temporary cardiac pacing in patient with accidental digoxin overdose and symptomatic bradycardia","volume":"102","author":"Chen","year":"2004","journal-title":"Cardiology"},{"key":"10.1016\/j.ccc.2021.03.006_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/hrt.36.4.405","article-title":"Phenytoin (diphenylhydantoin) treatment of massive digoxin overdose","volume":"36","author":"Rumack","year":"1974","journal-title":"Br Heart J"},{"issue":"4","key":"10.1016\/j.ccc.2021.03.006_bib42","first-page":"337","article-title":"The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model","volume":"42","author":"Hack","year":"2004","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.ccc.2021.03.006_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jemermed.2008.09.027","article-title":"The effects of intravenous calcium in patients with digoxin toxicity","volume":"40","author":"Levine","year":"2011","journal-title":"J\u00a0Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2021.03.006_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jemermed.2009.05.038","article-title":"Digoxin and calcium: the verdict is still out","volume":"39","author":"Gupta","year":"2010","journal-title":"J\u00a0Emerg Med"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070421000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070421000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:08:05Z","timestamp":1760062085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070421000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0749070421000178"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2021.03.006","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Drug Toxicity","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}